Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500 Futures
(0.05%) 5 298.25 points
Dow Jones Futures
(-0.07%) 38 763 points
Nasdaq Futures
(0.26%) 18 639 points
Oil
(0.26%) $77.19
Gas
(4.06%) $2.69
Gold
(0.01%) $2 346.00
Silver
(-0.26%) $30.36
Platinum
(-0.45%) $1 037.30
USD/EUR
(0.16%) $0.923
USD/NOK
(0.09%) $10.50
USD/GBP
(0.21%) $0.787
USD/RUB
(-1.06%) $89.47

Realtime updates for Synairgen PLC [SNG.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated3 Jun 2024 @ 03:29
25% discount on Stockinvest.us - Use code: Podcast

-4.59% £ 6.59

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 03:29):

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease...

Stats
Today's Volume 10 013.00
Average Volume 430 920
Market Cap 13.28M
EPS £0 ( 2024-04-25 )
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -1.320
ATR14 £0.247 (3.75%)

Synairgen PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Synairgen PLC Financials

Annual 2022
Revenue: £0
Gross Profit: £-102 000 (0.00 %)
EPS: £-0.0876
FY 2022
Revenue: £0
Gross Profit: £-102 000 (0.00 %)
EPS: £-0.0876
FY 2021
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.331
FY 2020
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.0946

Financial Reports:

No articles found.

Synairgen PLC Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Synairgen PLC

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.4792449474335 seconds
Number of API calls: 2
Number of DB calls: 8